A novel way in treatment of chronic plantar fasciitis: Combination of Extracorporeal shock wave therapy and topical corticosteroid with occlusive dressing

The effectiveness of shock wave therapy combined with topical corticosteroid in improvement of plantar fasciitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016081029296N1

Enrollment

Registered

2016-09-16

Start date

2015-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar Fasciitis. Plantar fascial fibromatosis

Interventions

Intervention 1: Intervention group: 4 session of shock wave weekly and 30 minutes before each session Clobetazol oint with occlusive dressing on plantar region. Focus-SW Shock : 2000 Energy: 0.2-0.3

Treatment - Other

Intervention group: 4 session of shock wave weekly and 30 minutes before each session Clobetazol oint with occlusive dressing on plantar region. Focus-SW Shock : 2000 Energy: 0.2-0.3 Frequency :4H

Control group: 4 session of shock wave, weekly and 30 minutes before each session Vaseline oil with occlusive dressing on plantar region. Focus-SW Shock : 2000 Energy: 0.2-0.3 Frequency :4Hz Ra

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age>18 y; Disease duration more than 6 months; Not responsive to conservative treatment; Exclusion criteria : Age less than 18 ;Open growth plate; pregnancy; bone tumor or other malignancy near treatment site; metabolic disease; open wound; Received systemic corticosteroid within the last month; Received topical corticosteroid in plantar fascia region within the last 6 weeks; Active infection; Skin disease; peripheral neuropathy; coagulopathy disorder; received heparin or warfarin; Past history of plantar ligament rupture; Past history of surgery in this region; vascular disease; Allergic reaction to sulfonamide, NSAID or Aspirin; Heart failure; tarsal tunnel syndrome

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: before intervention /1 month and 3 months after intervention. Method of measurement: Visual Analogue Scale.;Modified Roles and Maudsley score. Timepoint: before intervention /1 month and 3 months after intervention. Method of measurement: Modified Roles and Maudsley Scale.	—

Secondary

Measure	Time frame
Plantar fascia thickness. Timepoint: before and 3 months after intervention. Method of measurement: sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArghavan Mokhtarian

Isfahan University of Medical Science

a.mokhtarian@resident.mui.ac.ir+98 31 3668 5555

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026